BEIGENE News

BeiGene Analyst Ratings

Benzinga13:24 ET

BeiGene Analyst Ratings

BenzingaApr 8 12:33 ET

Bernstein Adjusts BeiGene's Price Target to $161 From $196, Maintains Market Perform Rating

MT NewswiresMar 27 06:25 ET

BeiGene Analyst Ratings

BenzingaMar 27 04:47 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Bluebird Bio (BLUE) and BeiGene (BGNE)

TipRanksMar 26 19:50 ET

BeiGene: Hold Recommendation Amidst Mixed Financial Indicators and Robust Drug Pipeline Growth

TipRanksMar 15 08:25 ET

UBS Cuts BeiGene Stock Target to $285.70, Maintains Buy Rating

InvestingFeb 29 10:32 ET

Analysts Are Bullish on These Healthcare Stocks: Athira Pharma (ATHA), BeiGene (BGNE)

TipRanksFeb 28 00:10 ET

BeiGene Analyst Ratings

BenzingaFeb 27 12:01 ET

BeiGene Hold Rating Upheld Amid Revenue Growth and Market Challenges

TipRanksFeb 27 07:18 ET

BeiGene: Balancing Robust Zanubrutinib Sales and Financial Challenges – A Hold Rating

TipRanksFeb 27 02:25 ET

Brukinsa's Market Dominance and BeiGene's Promising Pipeline Fuel Buy Rating and New Price Target

TipRanksFeb 26 16:45 ET

Analysts Are Bullish on Top Healthcare Stocks: BeiGene (BGNE), McKesson (MCK)

TipRanksFeb 26 07:20 ET

BeiGene Hold Rating Maintained Amid Mixed Drug Sales and Revised Financial Risk Profile

TipRanksFeb 19 05:45 ET

Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), BeiGene (BGNE) and Catalent (CTLT)

TipRanksFeb 12 08:20 ET

BeiGene Analyst Ratings

BenzingaFeb 6 08:56 ET

Analysts Are Bullish on These Healthcare Stocks: BeiGene (BGNE), Travere Therapeutics (TVTX)

TipRanksJan 25 06:50 ET

BeiGene's Hold Rating: Balancing BGB-16673's Promise With Market Realities

TipRanksJan 12 04:06 ET

Leerink Partners Sticks to Its Buy Rating for BeiGene (BGNE)

TipRanksJan 11 01:41 ET

BeiGene Holds Steady: A Balanced View Amidst Growth and Market Uncertainty

TipRanksJan 10 05:38 ET